Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.
Clinical trial NCT02278588 · COMPLETED
Trial details
- NCT number
- NCT02278588
- Sponsor
- State University of New York at Buffalo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.